Literature DB >> 27513334

Are virus-induced cancers more sensitive to checkpoint inhibitors?

Hassan Kanaan1, Hampig Raphael Kourie1, Ahmad Hussein Awada1.   

Abstract

Entities:  

Keywords:  HIV; HPV; cervical cancer; head and neck cancer; immune checkpoint inhibitors; ipilimumab; mutational load; nivolumab; pembrolizumab; virus-induced cancers

Mesh：

Substances：

Year:  2016        PMID： 27513334     DOI： 10.2217/fon-2016-0283

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  4 in total

Review 1.  The current status of immunotherapy for cervical cancer.

Authors:  Cecilia Orbegoso; Krithika Murali; Susana Banerjee
Journal:  Rep Pract Oncol Radiother       Date:  2018-05-18

Review 2.  Emerging Therapies in Penile Cancer.

Authors:  Antonio Machado Alencar; Guru Sonpavde
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

3.  PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma.

Authors:  Yu-Min Zhong; Kai Yin; Yu Chen; Zhi Xie; Zhi-Yi Lv; Jin-Ji Yang; Xue-Ning Yang; Qing Zhou; Bin-Chao Wang; Wen-Zhao Zhong; Ling-Ling Gao; Wen-Bin Zhou; Ji Chen; Hai-Yan Tu; Ri-Qiang Liao; Dong-Kun Zhang; Shui-Lian Zhang; Dan-Xia Lu; Hong-Bo Zheng; Heng-Hui Zhang; Yi-Long Wu; Xu-Chao Zhang
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

4.  Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.

Authors:  Huanhuan Wang; Qin Zhao; Yuyu Zhang; Qihe Zhang; Zhuangzhuang Zheng; Shiyu Liu; Zijing Liu; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.